Sucampo and Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation

Sucampo and Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation
N=435, respectively) in patients with IBS-C the most common adverse reactions (incidence > 4%) were nausea (8% vs 4%), diarrhea (7% vs 4%), and abdominal pain (5% vs 5%). Concomitant use of diphenylheptane opioids (e.g., methadone) may interfere …
Read more on GlobeNewswire (press release)

Chelmsford goes 'Behind Closed Doors' of teen drug abuse
Parents in line to browse through a mock bedroom filled with signs of substance abuse, on the stage of the CHS Performing Arts Center. doors1.JPG. doors2.JPG … Leading the two-hour "Behind Closed Doors" program, which explored current trends in teen …
Read more on wickedlocal.com/chelmsford

Comments are closed.